Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Algen Biotechnologies Inc
Profile last edited on: 2/28/22      CAGE: 8CWW9      UEI: LMQLCTBLR4M7

Business Identifier: Therapeutic discovery company building platform to decode functional gene networks
Year Founded
2018
First Award
2021
Latest Award
2021
Program Status
Active
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

665 3rd Street Suite 280
San Francisco, CA 94107
   N/A
   hello@algenbio.com
   www.algenbio.com
Location: Single
Congr. District: 12
County: San Francisco

Public Profile

Using CRISPR to uncover disease-driving RNA messages to find treatments for cancer and diseases with high unmet needs, Algen is harnessing the power of that system plus machine learning to find first-in-class drugs that modulate RNA messages at single-cell resolution

Extent of SBIR involvement

User Avatar
Phase I Awards
1
Phase II Awards
0
Conversion Rate
0.00%
Phase I Dollars
$350,000
Phase II Dollars
$0
Total Awarded
$350,000

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2021 1 NIH $350,000
Project Title: AlgenML: Drug target discovery platform for transcriptional reprogramming of MYCN-driven neuroblastoma

Key People / Management

  Chun-Hao Huang -- Co-Founder and CEO

Company News

There are no news available.